SlateStone Wealth’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-21,433
| Closed | – | – | 303 |
|
|
2024
Q3 | $0 | Hold |
21,433
| – | – | ﹤0.01% | 306 |
|
|
2024
Q2 | $0 | Hold |
21,433
| – | – | ﹤0.01% | 301 |
|
|
2024
Q1 | $0 | Hold |
21,433
| – | – | ﹤0.01% | 291 |
|
|
2023
Q4 | $3K | Sell |
21,433
-9,433
| -31% | -$1.32K | ﹤0.01% | 239 |
|
|
2023
Q3 | $3K | Hold |
30,866
| – | – | ﹤0.01% | 226 |
|
|
2023
Q2 | $11K | Buy |
30,866
+9,433
| +44% | +$3.36K | ﹤0.01% | 210 |
|
|
2023
Q1 | $8K | Hold |
21,433
| – | – | ﹤0.01% | 205 |
|
|
2022
Q4 | $19K | Sell |
21,433
-18,867
| -47% | -$16.7K | ﹤0.01% | 194 |
|
|
2022
Q3 | $63K | Hold |
40,300
| – | – | 0.02% | 181 |
|
|
2022
Q2 | $81K | Hold |
40,300
| – | – | 0.02% | 180 |
|
|
2022
Q1 | $94K | Hold |
40,300
| – | – | 0.02% | 178 |
|
|
2021
Q4 | $187K | Sell |
40,300
-9,433
| -19% | -$43.8K | 0.04% | 173 |
|
|
2021
Q3 | $379K | Hold |
49,733
| – | – | 0.09% | 127 |
|
|
2021
Q2 | $482K | Hold |
49,733
| – | – | 0.11% | 119 |
|
|
2021
Q1 | $411K | Hold |
49,733
| – | – | 0.1% | 121 |
|
|
2020
Q4 | $339K | Buy |
49,733
+37,733
| +314% | +$257K | 0.08% | 135 |
|
|
2020
Q3 | $134K | Hold |
12,000
| – | – | 0.03% | 170 |
|
|
2020
Q2 | $75K | Hold |
12,000
| – | – | 0.02% | 169 |
|
|
2020
Q1 | $22K | Hold |
12,000
| – | – | 0.01% | 170 |
|
|
2019
Q4 | $41K | Buy |
+12,000
| New | +$41K | 0.01% | 210 |
|